Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypothalamic-pituitary dysfunction after radiation for brain tumors

L S Constine1, P D Woolf, D Cann

  • 1Department of Radiation Oncology, University of Rochester Medical Center, NY 14642-8647.

The New England Journal of Medicine
|January 14, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological and non-pharmacological treatments for neuropathic pain: Systematic review and French recommendations.

Revue neurologique·2020
Same author

Pediatric Normal Tissue Effects in the Clinic (PENTEC): An International Collaboration to Analyse Normal Tissue Radiation Dose-Volume Response Relationships for Paediatric Cancer Patients.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019
Same author

Efficacy and safety of a T-type calcium channel blocker in patients with neuropathic pain: A proof-of-concept, randomized, double-blind and controlled trial.

European journal of pain (London, England)·2018
Same author

Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Cancer treatment reviews·2017
Same author

Early-stage mantle cell lymphoma: a retrospective analysis from the International Lymphoma Radiation Oncology Group (ILROG).

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Appropriateness of Medical Admissions and of Continued In-Patient Stay at an Acute Hospital.

Irish medical journal·2016

Cranial radiotherapy for brain tumors often leads to endocrine dysfunction, particularly hypothyroidism and hypogonadism. This study highlights the frequent occurrence of hypothalamic-pituitary abnormalities following radiation treatment in patients with brain tumors.

Area of Science:

  • Endocrinology
  • Oncology
  • Radiation Oncology

Background:

  • Cranial radiotherapy is a common treatment for brain tumors.
  • Growth hormone deficiency is a known complication, but other neuroendocrine abnormalities are often underestimated.

Purpose of the Study:

  • To investigate the prevalence and spectrum of endocrine dysfunction after cranial radiotherapy for brain tumors.
  • To assess hypothalamic-pituitary function in patients treated with cranial radiation.

Main Methods:

  • Studied 32 patients (aged 6-65) 2-13 years post-cranial radiotherapy.
  • Measured serum hormone concentrations (thyroid, gonadal, pituitary) at baseline and after stimulation.
  • Assessed hypothalamic-pituitary-adrenal axis function using metyrapone testing.

Related Experiment Videos

Main Results:

  • High rates of hypothyroidism (65% in cranial-only radiation group) and hypogonadism (61% in postpubertal patients) were observed.
  • Mild hyperprolactinemia was present in 50% of patients.
  • Subtle adrenal dysfunction was detected in 35% of patients via metyrapone testing.

Conclusions:

  • Cranial radiotherapy frequently causes hypothalamic-pituitary dysfunction in both children and adults with brain tumors.
  • Hypothyroidism and gonadal dysfunction are the most common endocrine abnormalities.
  • Adrenal axis abnormalities may also be present, underscoring the need for comprehensive endocrine monitoring.